FGF21 and type 2 diabetes mellitus: In rodents, exogenous administration of FGF21 has also shown promise in ameliorating DCM in T2D, possibly through AMPK mediated antioxidation and lipid-lowering effects, as well as sirtuin 3 axis-mediated regulation of mitochondrial integrity [17,21].